BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27345403)

  • 1. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer.
    Su Q; Zhang B; Zhang L; Dang T; Rowley D; Ittmann M; Xin L
    Oncogene; 2017 Feb; 36(5):618-627. PubMed ID: 27345403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
    Sizemore GM; Balakrishnan S; Hammer AM; Thies KA; Trimboli AJ; Wallace JA; Sizemore ST; Kladney RD; Woelke SA; Yu L; Fernandez SA; Chakravarti A; Leone G; Ostrowski MC
    Oncogene; 2017 Apr; 36(16):2297-2308. PubMed ID: 27797378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
    Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
    J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
    Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
    Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development.
    Pedrosa AR; Graça JL; Carvalho S; Peleteiro MC; Duarte A; Trindade A
    Prostate; 2016 Jan; 76(1):80-96. PubMed ID: 26419726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling.
    Delury C; Hart C; Brown M; Clarke N; Parkin E
    Biochem Biophys Res Commun; 2016 Mar; 472(1):255-61. PubMed ID: 26921446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression.
    Whelan JT; Kellogg A; Shewchuk BM; Hewan-Lowe K; Bertrand FE
    J Cell Biochem; 2009 Aug; 107(5):992-1001. PubMed ID: 19479935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
    Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
    Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.
    Liu H; Wang J; Zhang M; Xuan Q; Wang Z; Lian X; Zhang Q
    Breast Cancer Res Treat; 2017 Nov; 166(1):95-107. PubMed ID: 28730338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
    Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
    PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
    Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT
    Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAGGED1 expression is associated with prostate cancer metastasis and recurrence.
    Santagata S; Demichelis F; Riva A; Varambally S; Hofer MD; Kutok JL; Kim R; Tang J; Montie JE; Chinnaiyan AM; Rubin MA; Aster JC
    Cancer Res; 2004 Oct; 64(19):6854-7. PubMed ID: 15466172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.
    Korsten H; Ziel-van der Made AC; van Weerden WM; van der Kwast T; Trapman J; Van Duijn PW
    PLoS One; 2016; 11(1):e0147500. PubMed ID: 26807730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias.
    Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X
    Dis Model Mech; 2013 May; 6(3):710-20. PubMed ID: 23471917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
    Yang Z; Peng YC; Gopalan A; Gao D; Chen Y; Joyner AL
    Dis Model Mech; 2017 Jan; 10(1):39-52. PubMed ID: 27935821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells.
    Soylu H; Kırca M; Avcı S; Ozpolat B; Ustunel I
    Exp Mol Pathol; 2021 Apr; 119():104607. PubMed ID: 33482170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.
    Lu TL; Huang YF; You LR; Chao NC; Su FY; Chang JL; Chen CM
    Am J Pathol; 2013 Mar; 182(3):975-91. PubMed ID: 23313138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation.
    Yu Y; Zhang Y; Guan W; Huang T; Kang J; Sheng X; Qi J
    Mol Cancer Res; 2014 Jun; 12(6):830-42. PubMed ID: 24574517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma.
    Ratnacaram CK; Teletin M; Jiang M; Meng X; Chambon P; Metzger D
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2521-6. PubMed ID: 18268330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
    Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
    Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.